Paratek Pharmaceuticals
PRTK
#9361
Rank
C$0.18 B
Marketcap
C$3.15
Share price
0.00%
Change (1 day)
19.80%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -C$59.28 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are C$0.16 Billion. In 2022 the company made an earning of -C$64.03 Million a decrease over its 2021 earnings that were of -C$57.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$59.28 Million-7.42%
2022 -C$64.03 Million10.5%
2021 -C$57.95 Million-46.16%
2020 -C$0.11 Billion-31.93%
2019 -C$0.16 Billion11.12%
2018 -C$0.15 Billion21.19%
2017 -C$0.12 Billion-23.22%
2016 -C$0.16 Billion54.68%
2015 -C$98.87 Million309.5%
2014 -C$24.15 Million-29.88%
2013 -C$34.44 Million
2011 -C$5.31 Million-59.18%
2010 -C$13.01 Million-53.53%
2009 -C$28 Million-161.93%
2008 C$45.2 M-187.43%
2007 -C$51.7 Million11.93%
2006 -C$46.19 Million31.69%
2005 -C$35.08 Million32.4%
2004 -C$26.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-C$0.76 Billion 1,127.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$87.29 Million 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$29.14 M-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA